MyFinsight
Home
About
Contact
phat: the balance sheet
Income Statement
|
Cash Flow
|
Balance Sheet
For the quarter ending 2025-09-30, PHAT has $240,289K in assets.
Balance Sheets Overview
00
No enough data to generate the overview
Buy me a coffee
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Quarterly
123
Balance Sheets
2025-09-30
2025-06-30
Total assets
240,289
250,220
Total stockholders' deficit
-422,534
-405,834
Total liabilities and stockholders' deficit
240,289
250,220
Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Page 1
Buy me a coffee
Time Plot
Show the time plot by selecting a row from the table.
Balance Sheets
Inventory
$3,611K
Accounts receivable, net
$55,789K
Prepaid expenses and
other current assets
$13,227K
Cash and cash
equivalents
$135,156K
Other long-term
assets
$1,693K
Inventory, non-current
$24,101K
Restricted cash
$2,862K
Operating lease
right-of-use assets
$2,694K
Property and equipment,
net
$1,156K
Total current assets
$207,783K
Total assets
$240,289K
Accumulated deficit
-$1,463,110K
Total liabilities and
stockholders' deficit
$240,289K
Total stockholders'
deficit
-$422,534K
Additional paid-in capital
$1,040,570K
Common stock, 0.0001
par value...
$6K
Total liabilities
$662,823K
Other long-term
liabilities
$11,500K
Operating lease
liabilities
$2,123K
Revenue interest
financing liability
$348,984K
Long-term debt, net of
discount
$207,093K
Total current
liabilities
$93,123K
Current portion of
revenue interest...
$24,344K
Operating lease
liabilities, current
$591K
Accrued interest
$1,764K
Accrued expenses
$65,349K
Accounts payable
$1,075K
Subscribe for Financial Insights
Phathom Pharmaceuticals, Inc. (PHAT)
Phathom Pharmaceuticals, Inc. (PHAT)